Purpose Research on the prevalence of prostate cancer (PCa) screening and reasons for undergoing screening is limited. We aimed to identify the factors influencing PCa screening behavior and explore the underlying motivations among Korean men.
Materials and Methods This cross-sectional study used data from the 2023 Korean National Cancer Screening Survey, which employs a nationally representative random sampling method. This study included 1,784 men aged 40-74 years. The respondents reported their experiences with PCa screening. Multivariable logistic regression analysis was conducted to identify the factors associated with participation in PCa screening.
Results The lifetime PCa screening rate was 18.6%. Among screening modalities, transrectal ultrasonography was the most frequently used (31.9%), followed by prostate-specific antigen tests (25.6%) and digital rectal examinations (21.5%). The multivariable analysis identified several factors that significantly increased the likelihood of screening participation, including older age, living with a spouse, poor self-reported health, and abstinence from alcohol consumption in the previous 12 months. Men who had undergone colorectal cancer screening were more likely to participate in PCa screening (adjusted odds ratio, 4.01; 95% confidence interval, 2.03 to 7.93) than those who had not. The primary motivations for screening were recommendations from family or social networks (31.9%) and inclusion in health examination packages (24.3%), whereas healthcare provider recommendations (18%) and symptomatic concerns (5.7%) were the least influential.
Conclusion Our findings highlight the importance of providing evidence-based information for PCa screening recommendations and the need for improved communication and implementation of a shared decision-making approach for PCa screening in Korea.
Purpose This study aimed to evaluate the participation and follow-up test compliance rates and key performance indicators of the National Cancer Screening Program (NCSP) for colorectal cancer (CRC) from 2004 to 2017.
Materials and Methods The overall outcomes of the NCSP for CRC were analyzed using the NCSP data collected from 2004 to 2017 and the Korean Central Cancer Registry for CRC from 2005 to 2017. We cross-sectionally analyzed the participation and follow-up test compliance rates and performance indicators for each year. The trend of participation rates as an annual percentage change was assessed, and other statistical analyses were performed.
Results The screening participation rates increased from 7.3% in 2004 to 30.5% in 2017. Additionally, the screening rates were higher among individuals aged 60-69 years and National Health Insurance Service beneficiaries of low-income status. However, the adherence to the follow-up test decreased from 63% in 2004 to 32% in 2017. The follow-up tests using the double-contrast barium enema method decreased from 42.2% in 2004 to 0.3% in 2017. However, follow-up tests by colonoscopy increased from 21.0% in 2004 to 31.8% in 2017. Furthermore, the positivity, false-positive, and interval CRC rates decreased, whereas the specificity increased from 2004 to 2016, indicating improved performance of CRC.
Conclusion The participation rates and performance of the NCSP for CRC have steadily improved, whereas adherence to follow-up tests has decreased. Additionally, there is a rapid growth in colonoscopy volume as a follow-up test. Continued efforts are required to improve the follow-up rates.
Citations
Citations to this article as recorded by
Trends in Cancer-Screening Rates in Korea: Findings from the National Cancer Screening Survey, 2004-2023 EunKyo Kang, Kui Son Choi, Jae Kwan Jun, Yeol Kim, Hyeon Ji Lee, Chang Kyun Choi, Tae Hee Kim, Sun Hwa Lee, Mina Suh Cancer Research and Treatment.2025; 57(1): 28. CrossRef
Association Between Suicidal Ideation and Cancer Screening Uptake: Results from Middle-Aged and Older Adults in Korea Seong-Uk Baek, Jin-Ha Yoon Cancers.2025; 17(6): 956. CrossRef
Serum bilirubin levels and risk of colorectal cancer in Korean adults: results from the Korean Genome and Epidemiology Study-Health Examinee (KoGES-HEXA) Cohort Study Hwayoung Noh, Jeeyoo Lee, Nazlisadat Seyed Khoei, Laia Peruchet-Noray, Daehee Kang, Beatrice Fervers, Karl-Heinz Wagner, Aesun Shin, Heinz Freisling British Journal of Cancer.2024; 131(10): 1635. CrossRef
Association between Endoscopist Volume and Interval Cancers after Colonoscopy: Results from the National Colorectal Cancer Screening Program in Korea Dong Jun Kim, Nan-He Yoon, Jae Kwan Jun, Mina Suh, Sunhwa Lee, Seongju Kim, Ji Eun Kim, Hooyeon Lee Cancer Research and Treatment.2024; 56(4): 1164. CrossRef
Effectiveness of the Korean National Cancer Screening Program in Reducing Colorectal Cancer Mortality Hyeon Ji Lee, Kyeongmin Lee, Byung Chang Kim, Jae Kwan Jun, Kui Son Choi, Mina Suh Cancers.2024; 16(24): 4278. CrossRef
Effect of electroacupuncture on discomfort in patients undergoing colonoscopy: protocol for a multicentre, randomised, controlled clinical trial Xiangyu Sun, Liyue Lu, Yongqiang Wang, Chunchun Wang, Chao Lin, Kuangdi Xu, Yue Yong, Wenting Chen, Jiangang Song BMJ Open.2024; 14(12): e084628. CrossRef
National cancer screening program for colorectal cancer in Korea Seung Min Baik, Ryung-Ah Lee Annals of Surgical Treatment and Research.2023; 105(6): 333. CrossRef
Purpose
The Korean National Cancer Screening Program (KNCSP) has implemented two screening methods for gastric cancer—upper gastrointestinal series (UGIS) and endoscopy—for Koreans aged ≥40 years. We aimed to assess performance trends for both screening methods.
Materials and Methods
The KNCSP database was used to evaluate individuals who underwent screening from 2007 to 2016. The final gastric cancer diagnosis was ascertained by linking with the Korean Central Cancer Registry. We conducted a prospective, cross-sectional analysis to estimate performance indicators of gastric cancer screening by UGIS and endoscopy, stratified by sociodemographic factors.
Results
We found that screening rates for gastric cancer increased from 28% to 51.7% between 2007 and 2016, and that the rate of endoscopy use for gastric cancer screening increased sharply. Cancer detection rates (CDR) of UGIS and endoscopy were 0.41 and 2.25 per 1,000 screens in 2007–2008 and 0.26 and 1.99 in 2015–2016, respectively. Interval cancer rates (ICR) per 1,000 negative screenings were 1.33 (2007–2008) and 1.21 (2015–2016) for UGIS and 1.14 (2007–2008) and 0.88 (2015–2016) for endoscopy. The sensitivity of UGIS decreased from 23.6% (2007–2008) to 17.6% (2015–2016), whereas that of endoscopy increased from 66.4% (2007–2008) to 69.3% (2015–2016). Specificity was maintained at >99% for both methods over the study period.
Conclusion
The use of endoscopy for gastric cancer screening within the KNCSP has increased. Endoscopy has higher CDR, sensitivity, and specificity, and lower ICR estimates than does UGIS.
Citations
Citations to this article as recorded by
Cost Utility Analysis of National Cancer Screening Program for Gastric Cancer in Korea: A Markov Model Analysis Seowoo Bae, Hyewon Lee, Eun Young Her, Kyeongmin Lee, Joon Sung Kim, Jeonghoon Ahn, Il Ju Choi, Jae Kwan Jun, Kui Son Choi, Mina Suh Journal of Korean Medical Science.2025;[Epub] CrossRef
Korean Practice Guidelines for Gastric Cancer 2024: An Evidence-based, Multidisciplinary Approach (Update of 2022 Guideline) In-Ho Kim, Seung Joo Kang, Wonyoung Choi, An Na Seo, Bang Wool Eom, Beodeul Kang, Bum Jun Kim, Byung-Hoon Min, Chung Hyun Tae, Chang In Choi, Choong-kun Lee, Ho Jung An, Hwa Kyung Byun, Hyeon-Su Im, Hyung-Don Kim, Jang Ho Cho, Kyoungjune Pak, Jae-Joon Kim Journal of Gastric Cancer.2025; 25(1): 5. CrossRef
Association of Intensive Endoscopic Burden with Esophageal Cancer Detection: A Nationwide Cohort Study Yeunji Lee, Eunyoung Lee, Bumhee Park, Gil Ho Lee, Sun Gyo Lim, Sung Jae Shin, Choong-Kyun Noh, Kee Myung Lee Gut and Liver.2025; 19(1): 59. CrossRef
ACG Clinical Guideline: Diagnosis and Management of Gastric Premalignant Conditions Douglas R. Morgan, Juan E. Corral, Dan Li, Elizabeth A. Montgomery, Arnoldo Riquelme, John J. Kim, Bryan Sauer, Shailja C. Shah American Journal of Gastroenterology.2025; 120(4): 709. CrossRef
Knockdown of SLC7A5 inhibits malignant progression and attenuates oxaliplatin resistance in gastric cancer by suppressing glycolysis Yan Zhang, Jian Cao, Zheng Yuan, Jiahui Zhou, Hao Zuo, Xinsheng Miao, Xinhua Gu Molecular Medicine.2025;[Epub] CrossRef
Reducing gastric cancer mortality in the United States Kam C. (Nina) Li, Sarah Combs JAAPA.2025; 38(7): 13. CrossRef
Participation and Yield of Gastric Cancer Screening Programs: A Systematic Review and Meta-analysis Jiayue Wang, Xianzhu Zhou, Huiyun Zhu, Wenbo Zhu, Zhantong Wang, Shengyong Wu, Shihan Xu, Yifan Qiu, Chanjuan Wang, Zhaoshen Li, Yiqi Du Clinical Gastroenterology and Hepatology.2025;[Epub] CrossRef
Barriers to upper gastrointestinal screening among the general population in high-prevalence areas: a cross-sectional study Xin Chen, Yuan Ze, Wanya Yi, Yuling Yang, Renjuan Sun, Huiming Tu JBI Evidence Implementation.2024; 22(2): 218. CrossRef
Carbon footprint and cost reduction by endoscopic grading of gastric intestinal metaplasia using narrow‐band imaging Jun‐Hyung Cho, So‐Young Jin, Suyeon Park Journal of Gastroenterology and Hepatology.2024; 39(5): 942. CrossRef
Family history and gastric cancer incidence and mortality in Asia: a pooled analysis of more than half a million participants Dan Huang, Minkyo Song, Sarah Krull Abe, Md. Shafiur Rahman, Md. Rashedul Islam, Eiko Saito, Katherine De la Torre, Norie Sawada, Akiko Tamakoshi, Xiao-Ou Shu, Hui Cai, Atsushi Hozawa, Seiki Kanemura, Jeongseon Kim, Yu Chen, Hidemi Ito, Yumi Sugawara, Sue Gastric Cancer.2024; 27(4): 701. CrossRef
Efficacy and safety of three-dimensional magnetically assisted capsule endoscopy for upper gastrointestinal and small bowel examination Dong Jun Oh, Yea Je Lee, Sang Hoon Kim, Joowon Chung, Hyun Seok Lee, Ji Hyung Nam, Yun Jeong Lim, Thomas Lui Ka Luen PLOS ONE.2024; 19(5): e0295774. CrossRef
A mathematical simulation model to determine the optimal endoscopic screening strategy for detection of H. pylori-naïve gastric neoplasms Fumiaki Ishibashi, Kosuke Okusa, Yoshitaka Tokai, Toshiaki Hirasawa, Tomohiro Kawakami, Kentaro Mochida, Yuka Yanai, Chizu Yokoi, Yuko Hayashi, Shun-ichiro Ozawa, Koji Uraushihara, Yohei Minato, Hiroyuki Nakanishi, Hiroya Ueyama, Mikinori Kataoka, Yuzo To Gastric Cancer.2024; 27(5): 1078. CrossRef
Association between gastrectomy and the risk of type 2 diabetes in gastric cancer survivors: A nationwide cohort study Gyuri Kim, Kyung-do Han, So Hyun Cho, Rosa Oh, You-Bin Lee, Sang-Man Jin, Kyu Yeon Hur, Jae Hyeon Kim Diabetes & Metabolism.2024; 50(5): 101569. CrossRef
Nationwide Trends in Helicobacter pylori Eradication Therapies in Korea: Impact of Guideline Updates on Treatment Practices Byung Wook Jung, Yun Jin Kim, Chan Hyuk Park Helicobacter.2024;[Epub] CrossRef
Estimating Age-Specific Mean Sojourn Time of Breast Cancer and Sensitivity of Mammographic Screening by Breast Density among Korean Women Eunji Choi, Mina Suh, So-Youn Jung, Kyu-Won Jung, Sohee Park, Jae Kwan Jun, Kui Son Choi Cancer Research and Treatment.2023; 55(1): 136. CrossRef
Early Gastric Cancer: Update on Prevention, Diagnosis and Treatment Clara Benedetta Conti, Stefano Agnesi, Miki Scaravaglio, Pietro Masseria, Marco Emilio Dinelli, Massimo Oldani, Fabio Uggeri International Journal of Environmental Research and Public Health.2023; 20(3): 2149. CrossRef
Korean Practice Guidelines for Gastric Cancer 2022: An Evidence-based, Multidisciplinary Approach Tae-Han Kim, In-Ho Kim, Seung Joo Kang, Miyoung Choi, Baek-Hui Kim, Bang Wool Eom, Bum Jun Kim, Byung-Hoon Min, Chang In Choi, Cheol Min Shin, Chung Hyun Tae, Chung sik Gong, Dong Jin Kim, Arthur Eung-Hyuck Cho, Eun Jeong Gong, Geum Jong Song, Hyeon-Su Im Journal of Gastric Cancer.2023; 23(1): 3. CrossRef
Risk of upper gastrointestinal cancer and death in persons with negative screening results: results from the National Cancer Screening Program in South Korea Xuan Quy Luu, Kyeongmin Lee, Jae Kwan Jun, Mina Suh, Kyu-Won Jung, Il Ju Choi, Kui Son Choi Gastric Cancer.2023; 26(4): 580. CrossRef
Descriptive Analysis of Gastric Cancer Mortality in Korea, 2000-2020 Tung Hoang, Hyeongtaek Woo, Sooyoung Cho, Jeeyoo Lee, Sayada Zartasha Kazmi, Aesun Shin Cancer Research and Treatment.2023; 55(2): 603. CrossRef
Helicobacter pylori infection Peter Malfertheiner, M. Constanza Camargo, Emad El-Omar, Jyh-Ming Liou, Richard Peek, Christian Schulz, Stella I. Smith, Sebastian Suerbaum Nature Reviews Disease Primers.2023;[Epub] CrossRef
A 6-year nationwide population-based study on the current status of gastric endoscopic resection in Korea using administrative data Jae Yong Park, Mi-Sook Kim, Beom Jin Kim, Jae Gyu Kim Scientific Reports.2023;[Epub] CrossRef
How to Improve the Efficacy of Gastric Cancer Screening? Wladyslaw Januszewicz, Maryla Helena Turkot, Jaroslaw Regula Current Treatment Options in Gastroenterology.2023; 21(3): 241. CrossRef
Effect of gastric cancer screening on long-term survival of gastric cancer patients: results of Korean national cancer screening program Xuan Quy Luu, Kyeongmin Lee, Jae Kwan Jun, Mina Suh, Kyu-Won Jung, Kui Son Choi Journal of Gastroenterology.2022; 57(7): 464. CrossRef
Endoscopic Treatment of Superficial Gastric Cancer: Present Status and Future Hiroyuki Hisada, Yoshiki Sakaguchi, Kaori Oshio, Satoru Mizutani, Hideki Nakagawa, Junichi Sato, Dai Kubota, Miho Obata, Rina Cho, Sayaka Nagao, Yuko Miura, Hiroya Mizutani, Daisuke Ohki, Seiichi Yakabi, Yu Takahashi, Naomi Kakushima, Yosuke Tsuji, Nobuta Current Oncology.2022; 29(7): 4678. CrossRef
Impact of the COVID-19 Pandemic on Gastric Cancer Screening in South Korea: Results From the Korean National Cancer Screening Survey (2017–2021) Kyeongmin Lee, Mina Suh, Jae Kwan Jun, Kui Son Choi Journal of Gastric Cancer.2022; 22(4): 297. CrossRef
Status of Endoscopic Screening Strategies for Upper Gastrointestinal Tract Cancer Bin Lyu, Xiao-Liang Jin Cancer Screening and Prevention.2022; 000(000): 000. CrossRef